Stay updated on SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial
Sign up to get notified when there's something new on the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page.

Latest updates to the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page
- Check3 days agoChange DetectedThe page adds a recruitment status note signaling that participants are no longer being sought, and adds new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). It also updates the Intervention/Treatment heading formatting and the site revision label to v3.6.0.SummaryDifference0.4%

- Check11 days agoChange DetectedThe page revision has been updated from v3.5.4 to v3.5.5, representing a new patch/version of the ClinicalTrials.gov record. This likely accompanies small edits or improvements to the page layout or metadata, while the study details themselves remain unchanged.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page now displays Revision: v3.5.4, indicating a backend/template update. This change does not modify the displayed study details or navigation.SummaryDifference0.0%

- Check54 days agoChange DetectedThis updates the page’s technical revision/version label to v3.5.3 from v3.5.2, with no visible change to the study record details presented.SummaryDifference0.0%

- Check61 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check83 days agoChange DetectedAdded 'Squamous cell carcinoma of the head and neck' to the content and included a new Resources link to the Genetic and Rare Diseases Information Center.SummaryDifference0.1%

Stay in the know with updates to SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page.